Centenial Surgical Suture (BOM:531380) ROCE % : 9.62% (As of Dec. 2023)

View and export this data going back to 1996. Start your Free Trial

What is Centenial Surgical Suture ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Centenial Surgical Suture's annualized ROCE % for the quarter that ended in Dec. 2023 was 9.62%.

Centenial Surgical Suture ROCE % Historical Data

The historical data trend for Centenial Surgical Suture's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Centenial Surgical Suture ROCE % Chart

Centenial Surgical Suture Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

ROCE %

Get a 7-Day Free Trial

10.34

9.25

6.50

4.86

5.81

Centenial Surgical Suture Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															8.00	-1.61	9.37	8.88	9.62

Centenial Surgical Suture ROCE % Calculation

Centenial Surgical Suture's annualized ROCE % for the fiscal year that ended in Mar. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	21.642	/	( ( (613.397 - 242.043)	+	(664 - 290.738) )	/ 2 )
	=	21.642	/	( (371.354	+	373.262)	/ 2 )
	=	21.642	/	372.308
	=	5.81 %

Centenial Surgical Suture's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	36.772	/	( ( (696.267 - 314.096)	+	(0 - 0) )	/ 1 )
	=	36.772	/	( ( 382.171	+	0 )	/ 1 )
	=	36.772	/	382.171
	=	9.62 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Centenial Surgical Suture (BOM:531380) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Centenial Surgical Suture ROCE % Related Terms

Thank you for viewing the detailed overview of Centenial Surgical Suture's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Centenial Surgical Suture (BOM:531380) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Centenial Surgical Suture Ltd (BOM:531380) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

F-29, MIDC, Murbad, Thane, MH, IND, 421401

Website

https://www.centenialindia.com

Centenial Surgical Suture Ltd is an India-based company engaged in manufacturing, marketing, and selling quality atraumatic needles and sutures; absorbable - synthetic/natural (catgut plain and chromic); non-absorbable sutures; and other medical devices approved and licensed by Food and Drug Administration (FDA). The company's only segment is manufacturing and sale of Medical Devices. The company sells its products in India and also exports internationally; generating a vast majority of the revenue within India.

Centenial Surgical Suture (BOM:531380) Headlines

No Headlines